Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Postma

Showing results (31-40 of 135) with videos related to

Pageof 14
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Retrospective Public Health Impact of a Quadrivalent Influenza Vaccine in the United States Over the Period 2000-2014P Crépey, P de Boer, M J Postma, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 11, 1997
[Cost-effectiveness of influenza vaccination The Netherlands]A Reinders, M J Postma, T M Govaert, et al.
AIDS Care|December 17, 2003
The clinical and economic efficacy of HAART: a shift from inpatient medical to outpatient pharmaceutical care for HIV/AIDS patients in Northeastern ItalyA Tramarin, M J Postma, S Gerzeli, et al.
Sexually Transmitted Infections|December 14, 2007
Health economic methodology illustrated with recent work on Chlamydia screening: the concept of extended dominanceM J Postma, R de Vries, R Welte, et al.
Applied Health Economics and Health Policy|July 12, 2021
Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line SettingB Muresan, C Mamolo, J C Cappelleri, et al.
Orphanet Journal of Rare Diseases|January 19, 2017
Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugsC Schey, P F M Krabbe, M J Postma, et al.
Epidemiology and Infection|November 26, 2011
Modelling the impact of extended vaccination strategies on the epidemiology of pertussisM H Rozenbaum, R De Vries, H H LE, et al.
Pharmacoeconomics|January 28, 2014
Differential time preferences for money and quality of lifeM B Y Parouty, H H Le, D Krooshof, et al.
AIDS Care|April 22, 2016
Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in ZimbabweN Mafirakureva, B Dzingirai, M J Postma, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 1, 2002
[Pharmaco-economic aspects of vaccination against invasive pneumococcal infections in persons over 65 years of age; review of the literature on cost effectiveness analysis]M J Postma, M L A Heijnen, Ph Beutels, et al.
Pageof 14

Showing results (31-40 of 135) with videos related to

Sort By:
Pageof 14
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 21, 2016
Retrospective Public Health Impact of a Quadrivalent Influenza Vaccine in the United States Over the Period 2000-2014P Crépey, P de Boer, M J Postma, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 11, 1997
[Cost-effectiveness of influenza vaccination The Netherlands]A Reinders, M J Postma, T M Govaert, et al.
AIDS Care|December 17, 2003
The clinical and economic efficacy of HAART: a shift from inpatient medical to outpatient pharmaceutical care for HIV/AIDS patients in Northeastern ItalyA Tramarin, M J Postma, S Gerzeli, et al.
Sexually Transmitted Infections|December 14, 2007
Health economic methodology illustrated with recent work on Chlamydia screening: the concept of extended dominanceM J Postma, R de Vries, R Welte, et al.
Applied Health Economics and Health Policy|July 12, 2021
Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line SettingB Muresan, C Mamolo, J C Cappelleri, et al.
Orphanet Journal of Rare Diseases|January 19, 2017
Multi-criteria decision analysis (MCDA): testing a proposed MCDA framework for orphan drugsC Schey, P F M Krabbe, M J Postma, et al.
Epidemiology and Infection|November 26, 2011
Modelling the impact of extended vaccination strategies on the epidemiology of pertussisM H Rozenbaum, R De Vries, H H LE, et al.
Pharmacoeconomics|January 28, 2014
Differential time preferences for money and quality of lifeM B Y Parouty, H H Le, D Krooshof, et al.
AIDS Care|April 22, 2016
Health-related quality of life in HIV/AIDS patients on antiretroviral therapy at a tertiary care facility in ZimbabweN Mafirakureva, B Dzingirai, M J Postma, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 1, 2002
[Pharmaco-economic aspects of vaccination against invasive pneumococcal infections in persons over 65 years of age; review of the literature on cost effectiveness analysis]M J Postma, M L A Heijnen, Ph Beutels, et al.
Pageof 14